Insider holders · CIK 0001411685
Vistagen Therapeutics, Inc. · VTGN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Jerry B GinDirector | — | 100,000 | 100,000 | Jun 1, 2017 · 4:56 pm EDT | Form 4 |
| Shawn SinghPresident and CEO | 54,846 | 20,875 | 75,721 | Jul 2, 2026 · 4:16 pm EDT | Form 4 |
| Reid G. AdlerChief Legal Officer | 60,868 | — | 60,868 | Jul 2, 2026 · 4:34 pm EDT | Form 4 |
| Jon S SaxeDirector | 3,251 | 20,000 | 23,251 | Mar 14, 2019 · 5:22 pm EDT | Form 4 |
| Nick B. TresslerChief Financial Officer | 11,712 | — | 11,712 | Jul 2, 2026 · 4:17 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.